However, challenges remain, such as the necessity for a dual chamber pen for the company's drug CagriSema, which could impact patient conversion rates. The report also highlighted the importance ...

There's still hope for 12 WWE Superstars that they'll be able to punch their tickets to WrestleMania 41, but to make those dreams a reality, they'll have to survive the Elimination Chamber.

The goal of the trial was to evaluate atrial pacing compared with minimal ventricular pacing (i.e., back-up pacing) among patients with reduced left ventricular (LV) function and no clinical ...

The Identity pacemaker family, which includes the world's smallest dual-chamber pacemaker, provides clinicians with the most advanced pacemaker technology available, including the revolutionary AF ...

CagriSema combines the GLP-1 agonist semaglutide in Novo Nordisk's blockbuster weight-loss drug Wegovy with dual amylin and calcitonin receptor agonist cagrilintide. The company is hoping that the ...

Novo Nordisk is planning a new Phase III trial for CagriSema, the company’s next-generation obesity drug touted as a potential successor to Wegovy (semaglutide), as the company aims to quell ...

LONDON/SAN FRANCISCO, Feb 4 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema amid ...

LONDON/COPENHAGEN, Feb 5 (Reuters) - Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data published in December that disappointed ...

The Ceylon Chamber of Coconut Industries (CCCI), the ... proposal to import 200 million nuts urgently to avert a looming dual crisis. An unprecedented coconut shortage is threatening domestic ...